INVO Fertility, Inc. Files 8-K with Material Agreement

Ticker: IVF · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1417926

Sentiment: neutral

Topics: material-agreement, equity-sale, corporate-update

TL;DR

INVO Fertility (IVOF) filed an 8-K on 9/29/25 detailing a material agreement and equity sales.

AI Summary

On September 29, 2025, INVO Fertility, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. INVO Fertility, Inc. was formerly known as NAYA Biosciences, Inc. until October 22, 2024.

Why It Matters

This 8-K filing indicates significant corporate activity, including a new material agreement and potential equity transactions, which could impact the company's financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing involves a material definitive agreement and unregistered sales of equity, which can introduce financial and regulatory risks.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by INVO Fertility, Inc. on September 29, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What type of equity securities were sold by INVO Fertility, Inc. under the unregistered sales of equity securities item?

The filing mentions unregistered sales of equity securities, but the specific type and amount of securities are not detailed in the provided text.

When did INVO Fertility, Inc. officially change its name from NAYA Biosciences, Inc.?

INVO Fertility, Inc. changed its name from NAYA Biosciences, Inc. on October 22, 2024.

What is the SIC code for INVO Fertility, Inc.?

The Standard Industrial Classification (SIC) code for INVO Fertility, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

In which state is INVO Fertility, Inc. incorporated?

INVO Fertility, Inc. is incorporated in Nevada.

Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-29 17:31:13

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 29, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing